Trial Profile
Examination of the Bronchoprotective Effect of Endothelin Receptor Blockade in Asthma
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Ambrisentan (Primary) ; Bosentan (Primary)
- Indications Asthma; Bronchoconstriction
- Focus Pharmacodynamics
- 15 Jun 2012 New trial record